AAPL vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 06, 2026

AAPL

57.9
AI Score
VS
AAPL Wins

MRNA

34.1
AI Score

Investment Advisor Scores

AAPL

58score
Recommendation
HOLD

MRNA

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAPL MRNA Winner
Revenue 364.36B 534.00M AAPL
Net Income 101.46B -2.13B AAPL
Net Margin 27.8% -397.9% AAPL
Operating Income 122.43B -2.20B AAPL
ROE 94.4% -31.4% AAPL
ROA 26.5% -19.4% AAPL
Total Assets 383.27B 10.96B AAPL
Cash 39.54B 1.72B AAPL
Debt/Equity 0.77 0.09 MRNA
Current Ratio 1.00 2.29 MRNA
Free Cash Flow 110.20B -1.25B AAPL

Relative Price Performance (Last 90 Days)

AAPL 1M: +1.4% · 3M: +7.2% MRNA 1M: +36.5% · 3M: +154.7%

Current Technical Phase

AAPL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.3% over 20 days), RSI 54

RSI (14): 54.3 · Price: $332.89

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (48.1% over 20 days), RSI 71

RSI (14): 70.6 · Price: $203.21

Fundamentals Snapshot

Metric AAPL MRNA
Market Cap — —
Forward P/E 34.8 -42.4
Trailing P/E 38.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.5% -0.7%
Operating Margin 0.3% -5.6%
EPS 8.71 -7.98
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, AAPL is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.